Here you can find the latest TOPADUR news & events.
The Board of Directors of Topadur Pharma AG announces that Pascal Brenneisen will leave his position as CEO
Topadur Pharma AG today announces the appointments of PD Dr. Matthias Schäfer and Prof. Dr. Jay Siegel.
Topadur Pharma AG and Oshen Holdings SA Partner to Develop a Treatment for Alopecia
CHF 1.76 million is awarded from Innosuisse for the Phase 2a clinical trial with TOP-N53 in the treatment of digital ulcers
Topadur Pharma AG and Juvic Inc. Launch Transnational Collaboration for the Disease Management of Systemic Sclerosis
TOPADUR PHARMA AG has been awarded an Innosuisse grant to fund our collaborative project with Yonsei University and Juvic Inc.
Do you need more information or references? Media contact
